苏州立新制药有限公司
Suzhou Lixin Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
29
29 products shown
🇺🇸 DMF
5
5 products shown
🇪🇺 CEP
8
8 products shown
Total
42
registrations
🇨🇳 CDE 注册 (29)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Bortezomib 硼替佐米 | 179324-69-7 | Class A | Y20170000768 |
| Bumetanide 布美他尼 | 28395-03-1 | Class A | Y20240000515 |
| Choline Fenofibrate 非诺贝特酸胆碱 | 856676-23-8 | Class A | Y20220001245 |
| Clopidogrel 氯吡格雷 | 113665-84-2 | Class A | Y20190008178 |
| Clopidogrel Bisulfate 硫酸氢氯吡格雷（II型） | 113665-84-2 | Class A | Y20180001218 |
| Dacarbazine 达卡巴嗪 | 4342-03-4 | Class A | Y20190004496 |
| Erlotinib 盐酸厄洛替尼 | 183321-74-6 | Class A | Y20180000977 |
| Esomeprazole Magnesium 埃索美拉唑镁 | 119141-88-7 | Class A | Y20170001661 |
| Esomeprazole Sodium 埃索美拉唑镁 | 119141-88-7 | Class A | Y20170000446 |
| Fasudil 盐酸法舒地尔 | 103745-39-7 | Class A | Y20190007163 |
| Gefitinib 吉非替尼 | 184475-35-2 | Class A | Y20180001631 |
| Hydrochlorothiazide 氢氯噻嗪 | 58-93-5 | Class A | Y20190000492 |
| Hydrochlorothiazide 氢氯噻嗪 | 58-93-5 | Class A | Y20190009621 |
| Idebenone 艾地苯醌 | 58186-27-9 | Class A | Y20190007001 |
| Imatinib 硫酸艾玛昔替尼 | 152459-95-5 | Class I | Y20170000972 |
| Indapamide 吲达帕胺 | 26807-65-8 | Class A | Y20190009866 |
| Indapamide 吲达帕胺 | 26807-65-8 | Class A | Y20180000258 |
| Magnesium Aspartate 门冬氨酸镁 | 63596-52-1 | Class I | Y20250000631 |
| Magnesium Aspartate 门冬氨酸镁 | 63596-52-1 | Class I | Y20230000726 |
| Oxaliplatin 奥沙利铂 | 61825-94-3 | Class A | Y20190006084 |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | Class A | Y20200001188 |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | Class A | Y20170000046 |
| Potassium Aspartate 门冬氨酸钾 | 1115-63-5 | Class A | Y20170001251 |
| Ritodrine 盐酸利托君 | 26652-09-5 | Class A | Y20190007663 |
| Sitagliptin 西格列汀 | 486460-32-6 | Class A | Y20210000506 |
| Temozolomide 替莫唑胺 | 85622-93-1 | Class A | Y20170000549 |
| Tenofovir Alafenamide 富马酸丙酚替诺福韦 | 379270-37-8 | Class A | Y20200000390 |
| Tenofovir Disoproxil 酒石酸替诺福韦二吡呋酯 | 201341-05-1 | Class A | Y20190006876 |
| Ticagrelor 替格瑞洛 | 274693-27-5 | Class A | Y20190000285 |
🇺🇸 DMF 注册 (5)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Hydrochlorothiazide 氢氯噻嗪 | 58-93-5 | - | 2003-08-08 |
| Idebenone (non-sterile) 艾地苯醌 | 58186-27-9 | - | 2017-08-28 |
| Nilotinib Hydrochloride Monohydrate | 923288-90-8 | - | 2017-04-14 |
| Pemetrexed Disodium (non Sterile) | 150399-23-8 | - | 2011-12-27 |
| Semaglutide 司美格鲁肽 | 910463-68-2 | - | 2023-07-19 |
🇪🇺 CEP 注册 (8)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Bumetanide 布美他尼 | 28395-03-1 | CEP 2024-381 - Rev 00 | - |
| Dacarbazine 达卡巴嗪 | 4342-03-4 | R1-CEP 2010-315 - Rev 02 | - |
| Hydrochlorothiazide 氢氯噻嗪 | 58-93-5 | CEP 2012-250 - Rev 02 | - |
| Indapamide 吲达帕胺 | 26807-65-8 | R1-CEP 2012-182 - Rev 01 | - |
| Pemetrexed Disodium 2.5-hydrate | 357166-30-4 | CEP 2021-072 - Rev 01 | - |
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | CEP 2020-398 - Rev 01 | - |
| Temozolomide 替莫唑胺 | 85622-93-1 | R0-CEP 2020-359 - Rev 00 | - |
| Ticagrelor 替格瑞洛 | 274693-27-5 | CEP 2022-312 - Rev 00 | - |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-04-09 07:23:01